The global periodontal treatment market is estimated to grow at a CAGR of nearly 8.0% during the forecast period. The major factors contributing to the market growth include the significant rise in the prevalence of diabetes, rising geriatric population, and increasing awareness regarding dental problems. As per the International Diabetes Federation (IDF), in 2019, the number of individuals aged 20-79 years living with diabetes were 463 million, which is expected to reach 700 million by 2045. The share of individuals living with type 2 diabetes is increasing in several countries. One in five individuals aged more than 65 have diabetes.

Type 1 diabetes was reported in over 1.1 million children and adolescents. There is an increased risk of developing type 2 diabetes in 374 million individuals. These rising incidences of diabetes have increased the concerns of periodontal conditions. Diabetes is among major risk factors for periodontal disease as compared to people without diabetes, as people living with diabetes are more prone to contracting infections. This contributes to the increasing demand for periodontal medications and surgical treatment.

Systemic antibiotic treatment is used to strengthen mechanical periodontal therapy. It facilitates the host defense system by killing subgingival pathogens and thereby supports to overcome infection. These pathogens remain after traditional mechanical periodontal treatment. The bacteria susceptibility to antibiotics is expected to be a major factor for the effectiveness of systemic antibiotics to treat periodontal diseases. Systemic antibiotics along with scaling and root planing (SRP), may provide extra benefit as compared to SRP alone in the periodontitis treatment, in terms of change in pocket depth, clinical attachment loss (CAL), and minimize the risk of additional CAL loss.

Market Segmentation

The global periodontal treatment market is classified based on therapy, which is segmented into surgical and non-surgical therapies. Non-surgical therapies are further classified into local antibiotics, systemic antibiotics, laser treatment, and others. 

Non-surgical therapies are anticipated to witness significant growth during the forecast period

Increasing demand for dental implant procedures is expected to contribute significantly to the increasing share of non-surgical therapies for periodontal diseases. Implants enable to preserve tooth-supporting bone that certainly weakens after tooth loss. Bone loss is one of the key hidden consequences of teeth loss. Dental implants have an accomplishment rate of more than 95%, higher as compared to other tooth-replacement alternatives. Dental implants are ideal for nearly anyone who has lost one or more teeth and want to restore their chewing ability or appearance. However, it is essential that the bone tissue of the patient is completely developed. Therefore, these procedures are not performed in people less than 18 years of age.

Global Periodontal Treatment Market Share by Therapy, 2018 (%)

Regional Outlook

The global periodontal treatment market is classified into North America, Europe, Asia-Pacific, and Rest of the World. In 2018, North America is anticipated to hold a significant share in the market owing to the increasing prevalence of periodontal diseases in the region. As per the Centers for Disease Control and Prevention (CDC), in the US, during the period, 2009-2010, 47.2% of adults with the age of 30 years and over have some form of periodontal condition. The condition increases with age, the percentage of individuals with the periodontal disease aged 65 years and over was 70.1%. This contributes to the increasing demand for periodontal therapies in the region.

Global Periodontal Treatment Market Growth, by Region 2019-2025

Market Players Outlook

The major players operating in the market include 3M Co., Dentsply Sirona Inc., The Straumann Group, Medtronic plc, and Bausch Health Companies, Inc. The market players adopted several strategies to expand market share and gain a competitive advantage. These strategies include mergers and acquisitions, partnerships and collaborations, and product launches. For instance, in October 2019, DenMat Holdings, LLC increased its range of Soft Tissue Management products by launching Perio Restore System. It is a non-invasive home treatment system for the treatment and prevention of periodontal condition. The Perio Restore System is formulated to fight against build-up of bacteria and prevent further infection. 

It contains a customized tray developed to gently push a 1.7% Hydrogen Peroxide gel into the periodontal pocket and break up biofilm to remove and restrict bacteria from recolonizing. With the use of Perio Restore System, patients with periodontal conditions can experience a decrease in bacteria with each10-15-minute application. The digitally designed customized tray features unique reservoirs to hold the gel in place to treat bacteria below the gumline and interproximally, for a deeper reach than other non-invasive treatments.

The Report Covers

• Market value data analysis of 2018 and forecast to 2025.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global periodontal treatment market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.